CHAI Raises $400 Million in Funding
chaitjo · x · 2026-07-15
CHAI announced the completion of a $400 million funding round led by Dimension, with participation from Index, Kleiner Perkins, and Sequoia.
The post reflected on the company's journey from sharing early office space to its current focus on generative molecular design, having secured partnerships with Lilly, Pfizer, and Novartis. It also mentioned their release of the open-source Chai-1, positioned as a frontier model for biomolecular interactions. The author emphasized that this funding round will reshape preclinical and even clinical-stage drug discovery and R&D.
Related event: AI Drug Discovery Firm Chai Raises $400M(3 posts)→
More from Venture
- Anthropic's IPO Filing Goes Public, Revealing Strong Revenue and Massive Spending — KateClarkTweets · 2026-10-27
- Gary Marcus flags Nov 11-15: Anthropic's Q3 S-1 update and earliest IPO window — GaryMarcus · 2026-10-27
- Kimi K3 Is 'Open' Until You Succeed: License Caps Free Use at $20M Revenue — alex_verem · 2026-10-27
- Anthropic hits $16.3B H1 revenue and first-ever $974M quarterly operating profit — iruletheworldmo · 2026-10-27
- Indie dev's ASO experiment: localization via ASC CLI lifts impressions 13x to 2,853/day — rudrank · 2026-10-27
- Anthropic's S-1 reveals over half of $100K+ customers now use both Claude Platform and first-party apps — TechCrunch AI · 2026-10-27